BioSpace News Archive

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company , today announced that it has signed an agreement with Camargo Pharmaceutical Services to facilitate the writing and submission of the Investigational New Drug application

BioCurate , an independently operated joint venture between the University of Melbourne and Monash University, and with support of the Victorian State Government, today announced the appointment of Dr Damien Bates as Acting CEO, with Founding CEO Dr C. Glenn Begley transitioning to a specialist scientific, commercial and strategic advisory role

Bioelectronica Corporation (“Bioelectronica”) today announced the closing of an investment by Proxima Ventures and Co-win Ventures to advance the company’s innovations in digital biochemistry, from novel assay development to scalable electrofluidics.

MTF Biologics has been awarded a group purchasing agreement for Regenerative Skin Tissues with Premier.

- Phase 1 clinical study recruitment in healthy volunteers is expected to start in Q1 2021 - - Pre-clinical studies have demonstrated a strong anti-fibrotic effect in animal models of fibrosis - - Recently completed Phase 1 trial in oncology patients demonstrated good safety profile -

As COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

The largest incentive prize in history to attract and inspire innovators to develop and scale carbon removal solutions to combat climate change.

Amicus Optimized Transgene Show Greater Substrate Reduction than Wild Type Construct Across All Tissues and Doses Further Validates Combining Amicus-Engineered Transgenes with Penn’s AAV Gene Therapy Technologies to Develop Next Generation Gene Therapies

As consumer awareness for vitamins and supplements continue to proliferate, vitamin K market size is expected to grow considerably.